Circular Dichroism Spectroscopy: CD measurements were performed on a Jasco J-810 spectropolarimeter equipped with a Peltier unit for temperature control. All samples were prepared in 50 mM potassium phosphate buffer (pH 7.5) with protein concentrations ranging from 10 to 25 µM as determined by the absorbance at 280 nm. The spectra were collected in the far-UV range using a cuvette with a 1 mm path length at 25 °C with a scan rate of 20 nm/min, a response time of 2 s, a bandwidth of 2 nm and an average of three accumulation scans. For thermal denaturation experiments, the change in ellipticity at 222 nm was monitored from 4 to 85 °C with a temperature gradient of 1.0 °C/min and data pitch of 0.2 nm.
Determination of Oligomeric State:
The oligomeric state for all enzyme variants was determined by size-exclusion chromatography on either a Superdex 200, 10/300 GL column (GE Healthcare) or a Bio SEC-3 HPLC column (Agilent, Santa Clara, CA). Protein samples (50 µM) were prepared in 40 mM TrisHCl (pH 8.0), 300 mM NaCl. Retention times for the different oligomers were calibrated against protein standards of known molecular weight.
Crystallography:
Following protein purification, sample aliquots were exchanged into protein crystallization buffer (10 mM Tris (pH8.0), 10 mM NaCl, 10 µM PMSF) and concentrated to ~40 mg/mL by ultrafiltration. Early crystallization trials, using conditions reported for wild type OYE (33), were largely unsatisfying. Hence, crystallization screens were conducted to find optimal conditions for crystallizing selected cpOYE variants by the sitting drop method at 16°C (cpOYE154: PEG 2000 MME (30%) + 0.1 M thiocyanate (pH 5.0); cpOYE303: 16-18% PEG 3350, 0.2 M MgCl2, 0.1 M Tris-HCl (pH 8); cpOYE303T: 2 M ammonium sulfate, 0.1 M HEPES (pH 7.5)). Crystals typically appeared within 48 to 72 h and were acquired with a nylon loop (Hampton Research). After quickly transferring them to the well solution containing 20% ethylene glycol, they were flash-frozen directly in liquid nitrogen, stored and later used in X-ray diffraction experiments. For the structure with p-hydroxybenzaldehyde in the active site, protein crystals were soaked in inhibitor (11 mM) for 10 min, followed by cryoprotection.
S! 3 X-ray data was collected at the 22-ID and 22-BM SER-CAT synchrotron beamlines (Advanced Photon Source, Argonne National Laboratory) using their experimental control system SERGUI. The diffraction datasets were processed using the program HKL2000.(47) Phasing via molecular replacement, map production, and model refinement were conducted using the PHENIX software suite.(48) Maps and models were visualized with COOT (49), as well as by conducting manual model manipulation during refinement rounds. Molecular replacement utilized protein coordinates of the previously reported wildtype OYE1 structure (PDB code: 1OYA)(33) as the initial search model; this model was modified on the basis of evident changes in backbone connectivity of the permutants in the electron density using COOT.
The coordinates for cpOYE154 (1.25Å), cpOYE303 (2.69Å), cpOYE303 with bound inhibitor (2.47Å), and truncated cpOYE303 (1.55Å) were deposited in the PDB (accession codes 4RNX, 4RNU,4RNV, and 4RNW, respectively).
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